Mirum Pharmaceuticals director Laura Brege sells $1.33 million in common shares
MIRM•Laura Brege sold 14,167 Mirum Pharmaceuticals common shares on Nov. 11, 2026, in transactions valued at about $1.33 million, after exercising options to acquire the same number of shares. Her direct holdings totaled 15,703 shares after the transactions, disclosed in a Nov. 13 Form 4.
1. Share transactions disclosed
Mirum Pharmaceuticals director Laura Brege sold 14,167 common shares on Nov. 11, 2026: 10,907 shares at $94.05 each and 3,260 at $94.74 each. She also exercised options to acquire 14,167 shares at $16.71 per share. Her direct common stock holdings totaled 15,703 shares following the transactions, according to a Form 4 dated Nov. 13, 2026.
